• Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
FENG Yuan, Email: fynotebook@hotmail.com; CHEN Mao, Email: hmaochen@vip.sina.com
Export PDF Favorites Scan Get Citation

Transcatheter aortic valve replacement (TAVR) is a mature technology. Because of the complicated valvular anatomy and the severe non-symmetrical valve calcification, the patient with bicuspid aortic valve stenosis (BAVs) once having a lower procedure successful rate, was considered as the relative contradiction for TAVR. However, with the application of the skirted and retrievable next generation prosthesis system, the outcomes of the treatment have been greatly improved. In this article, we summarized the current situation of TAVR applied in BAVs, and the outcomes difference of the old and new generation prosthesis systems.

Citation: OU Yuanweixiang, LI Yijian, WANG Zijie, ZHAO Zhengang, LIAO Yanbiao, WANG Xi, WEI Xin, PENG Yong, XU Yuanning, FENG Yuan, CHEN Mao. The application of transcatheter aortic valve replacement in patients with bicuspid aortic valve stenosis. West China Medical Journal, 2018, 33(2): 218-222. doi: 10.7507/1002-0179.201711146 Copy

  • Previous Article

    A Meta-analysis of percutaneous access versus surgical cutdown in transfemoral transcatheter aortic valve implantation
  • Next Article

    如何治疗主动脉瓣狭窄合并体外膜肺氧合支持下的心源性休克